Підписатись
William Fyke
William Fyke
Pediatric & Medical Genetics Physician (MD, PhD) at NYP Columbia (Morgan Stanley Children's Hospital
Підтверджена електронна адреса в nyp.org
Назва
Посилання
Посилання
Рік
Communication and social interaction in the cannabinoid‐type 1 receptor null mouse: Implications for autism spectrum disorder
W Fyke, M Premoli, V Echeverry Alzate, JA López‐Moreno, ...
Autism Research 14 (9), 1854-1872, 2021
222021
FMR1 and Autism, an Intriguing Connection Revisited
W Fyke, M Velinov
Genes 12 (8), 1218, 2021
212021
Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL‐α, induces autism spectrum disorder‐like and co‐morbid phenotypes in adult C57BL/J mice
W Fyke, JM Alarcon, M Velinov, KK Chadman
Autism Research 14 (7), 1375-1389, 2021
152021
Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19
R Mendoza, N Saha, A Momeni, E Gabutan, M Alawad, A Dehghani, ...
Heliyon 7 (6), 2021
122021
Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes
RP Mendoza, W Fyke, D Daniel, E Gabutan, B Das, H Bajaj, M Easy, ...
Human immunology 82 (4), 255-263, 2021
92021
Pharmacological inhibition of BKCa channels induces a specific social deficit in adult C57BL6/J mice.
W Fyke, JM Alarcon, M Velinov, KK Chadman
Behavioral Neuroscience 135 (4), 462, 2021
42021
Low cost, injection molded, nasopharyngeal swabs for addressing global diagnostic supply shortages
MR Martinez, R Mendoza, D Perry, E Gabutan, W Fyke, E Faber, SJ Saggi, ...
MedRxiv, 2021.07. 19.21260235, 2021
22021
P422: Novel familial variants in the TDGS gene associated with Catel-Manske syndrome and distinct phenotypes between male siblings
W Fyke, E Pereira
Genetics in Medicine Open 2, 2024
2024
Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the Fmr1-KO Mouse Model of Fragile X …
M Premoli, W Fyke, L Bellocchio, V Lemaire, M Wolley-Roberts, ...
Cells 12 (15), 1927, 2023
2023
Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces ASD and co-morbid ASD phenotypes in adult C57BL/J mice
W Fyke, JM Alarcon, M Velinov, K Chadman
Molecular Genetics and Metabolism 132, S82, 2021
2021
Identifying therapeutic targets for the treatment of Fragile X Syndrome: Implications for Autism Spectrum Disorders
W Fyke
Université de Bordeaux; State university of New York, 2021
2021
FMR1 and Autism, an Intriguing Connection Revisited. Genes 2021, 12, 1218
W Fyke, M Velinov
s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2021
2021
BKCa Channels during Early Developmental Periods as Therapeutic Targets for Fragile X Syndrome
W Fyke, K Le Corf, M Ginger, A Frick, S Pietropaolo
ANNALS OF NEUROLOGY 84, S47-S47, 2018
2018
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–13